Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-20-005055
Filing Date
2020-07-21
Accepted
2020-07-21 07:06:05
Documents
2
Period of Report
2020-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_072120.htm 6-K 4452
2 PRESS RELEASE exh_1.htm EX-1 8783
  Complete submission text file 0001171843-20-005055.txt   14181
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 201037667
SIC: 2834 Pharmaceutical Preparations